Hemalatha Rangarajan, MD¹, Deepak Chellapandian, MD², Rasha Atshan, MS^3*, Kwang Wooahn, PhD^3,4*, Akshay Sharma, MBBS⁵, Kirk R. Schultz, MD⁶, Parinda A. Mehta, MD⁷, Christine L. Phillips, MD⁸, Larisa Broglie, MD^3,9 and Prakash Satwani, MD, MBBS¹⁰

¹Department of Pediatric Hematology, Oncology, Blood and Marrow Transplantation, Nationwide Childrens Hospital, Columbus, OH
²John's Hopkin's Medical Institution, St Petersburg, FL
³CIBMTR® (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI
⁴Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI
⁵Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN
⁶Department of Pediatric Hematology, Oncology and Bone Marrow Transplant, British Columbia's Children's Hospital, The University of British Columbia, Vancouver, BC, Canada
⁷Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital, Cincinnati, OH
⁸Cancer and Blood Diseases Institute, Division of Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
⁹Division of Pediatric Hematology/Oncology/Blood and Marrow Transplant, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI
¹⁰Department of Pediatrics, Columbia University Medical Center, New York, NY

Thomas Pabst¹, Thomas Lehmann, MD^2*, Petra Pichler^3*, Sigrid Machherndl-Spandl, MD^4*, Michael Gregor, MD^5*, Jeroen S. Goede, MD^6*, Sabine Gerull, MD⁷, Daniel Maria Mayer, MD^8*, Jean-François Lambert, MD⁹, Catherine Germanier^10* and Georg Stüssi, MD^11*

¹Department of Medical Oncology, Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland
²Department of Oncology and Hematology, Medical Research Center, Cantonal Hospital St. Gallen, St. Gallen, Switzerland
³Clinical Department for Internal Medicine, University Hospital St Poelten, Karl Landsteiner University of Health Sciences, St. Poelten, Austria
⁴Ordensklinikum Linz, Linz, Austria
⁵Division of Hematology, Cantonal Hospital of Lucerne, Lucerne, Switzerland, Lucerne, Switzerland
⁶Cantonal hospital Winterthur, Winterthur, Switzerland
⁷Cantonal hospital Aarau, Aarau, Switzerland
⁸Barmherziger Brüder Hospital Graz, Graz, Austria
⁹Hospital of Nyon, Nyon, Switzerland
¹⁰AbbVie AG, Cham, Switzerland
¹¹Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale, Bellinzona, Switzerland

Daniel J. Olivieri, MD¹, Alexis Berridge-Green^2*, Megan Othus, PhD^2,3, Anna B. Moseley, MS^2,3*, Jerald P. Radich, MD⁴, Anjali S. Advani, MD⁵, Harry P. Erba, MD, PhD⁶ and Roland B. Walter, MD, PhD, MS^4,7

¹Department of Medicine, University of Washington, Seattle, WA
²Public Health Science Division, Fred Hutchinson Cancer Center, Seattle, WA
³SWOG Statistics and Data Management Center, Seattle, WA
⁴Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA
⁵Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
⁶Duke University Cancer Institute, Durham, NC
⁷Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA

Fatima Tuz Zahra, MBBS¹, Faustine Ong, MD^2*, Daniel Walgenbach, MD^3*, Onyee Chan, MD^4*, Katherine Tobon, PharmD, BS^5*, Jeffrey E Lancet, MD⁶, David Sallman, MD⁶, Rami S. Komrokji, MD⁶, Andrew T. Kuykendall, MD⁶, Eric Padron, MD⁶, Alison R. Walker, MD, MBA, MPH⁷, Zhuoer Xie, MD, MS⁶ and Seongseok Yun, MD, PhD⁶

¹Department of Oncological Sciences, H. Lee Moffitt Cancer Center, University of South Florida, ALBANY, NY
²Department of Oncological Sciences, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL
³Department of Internal Medicine, University of South Florida, Tampa, FL
⁴H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁵Department of Pharmacy, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁶Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁷Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Wesley Chapel, FL

Kamar Godder, MD^1*, Ashley C. Woods, MD^2*, Dianne D. Pulte, MD³, Emily Jen, MD, PhD^2*, Nina Kim^4*, Robert Le, MD^2*, Catherine Lerro, PhD^3*, Donna Rivera, MS, PharmD^5*, Gulsum Pamuk, MD^2*, Nicole Gormley, MD², Marc R. Theoret, MD^6*, Kelly J Norsworthy, MD⁷ and Angelo De Claro, MD⁸

¹CDER, Food and Drug Administration, Coral Gables, FL
²US Food and Drug Administration, Silver Spring, MD
³FDA, Silver Spring, MD
⁴U.S. Food and Drug Administration, Silver Spring, MD
⁵Oncology Center or Excellence, US Food and Drug Administration, Silver Spring, MD
⁶Center for Drug Evaluation and Research, Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD
⁷Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD
⁸Food and Drug Administration, Bethesda, MD

Naman Sharma, MD¹, Yating Wang, MS^2*, Hossein Sadrzadeh, MD^3*, Angela C. Tramontano^4*, John Mark Sloan, MD⁵, Richard M. Stone, MD^4,6 and Lachelle D. Weeks, MD, PhD⁶

¹Dana-Farber Cancer Institute, Windsor, CT
²Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
³Massachusetts General Hospital, BOSTON, MA
⁴Dana-Farber Cancer Institute, Boston, MA
⁵Boston University Chobanian & Avedisian School of Medicine, Boston, MA
⁶Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Tina Y Zhang, MD^1,2, Alex Y Ge, MD^3*, Mara Meyer Epstein, ScD^3* and Shyam Ajay Patel, MD, PhD^3,4

¹Department of Medicine, University of Massachusetts Memorial Medical Center, Worcester, MA
²Division of Hematology/Oncology, University of Massachusetts Chan Medical School, Worcester, MA
³Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA
⁴Division of Hematology/Oncology, University of Massachusetts Memorial Medical Center, Worcester, MA

Robert Morlock, PhD^1*, Andréa Martins Bayer^2*, Amy Morlock^3*, Monika Wroclawska, MD, MBA⁴ and Chad Gwaltney^5*

¹Probridge Solutions, Ann Arbor, MI
²MorphoSys US Inc, Boston, MA
³Acumen Health Research Institute, Ann Arbor, MI
⁴Novartis AG, Basel, Switzerland
⁵Gwaltney Consulting, Westerly, RI

Victoria A. Vardell, MD¹ and Srinivas K Tantravahi, MD²

¹Huntsman Cancer Institute, Division of Hematology and Hematological Malignancies, University of Utah, Salt Lake City, UT
²Huntsman Cancer Institute, Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake Cty, UT

Aseel Saadeh, MD^1*, Farah Al-Bitar, MD^2*, Omar Al Ta’ani, MD^3*, Ahmed A Abdulelah, MD^4,5*, Asra Abeer Usmani, MBBS^2*, Dayana Jibrin, MD^2*, Michael Haddadin, MBBS⁶ and Katie Scott, MD^7*

¹Department of Internal Medicine, Geisinger Medical Center, Danville, PA
²Department of Pediatrics and Adolescent Medicine, Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, MI
³Department of Internal Medicine, Allegheny Health Network, Pittsburgh, PA
⁴Royal Papworth Hospital, Cambridge, United Kingdom
⁵Edinburgh Medical School, The University of Edinburgh, Edinburgh, United Kingdom
⁶Fred & Pamela Buffet Cancer Center, University of Nebraska Medical Center, Omaha, NE
⁷Department of Pediatrics, Division of Pediatric Hematology/Oncology, Bronson Methodist Hospital, Kalamazoo, MI

Mihir N. Patel, BS¹, Allison O. Taylor, MD, MS^2*, Brenda Branchaud, BA^3*, David Campbell, BA^3*, Anneli N. Kramer, MS^3*, Kris W. Herring, PhD, MSc^3*, Jesse D. Troy, PhD^4* and Thomas W. LeBlanc, MD, MA, MS^5,6

¹Duke University School of Medicine, Durham, NC
²Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC
³Duke Cancer Institute, Durham, NC
⁴Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC
⁵Duke Cancer Institute, Duke University School of Medicine, Durham, NC
⁶Duke Cancer Institute, Hillsborough, NC

Michelle Nwachukwu, DO¹, Garth Rauscher^2*, Ivy Abraham^3*, John G Quigley⁴, Judith Sayad^5*, Ami Dave^6*, Andrew Wilmington, MD^7*, Chen Zhang, MD, MS^8*, Anand Ashwin Patel, MD⁹, Andrew Palmer, BS¹⁰, Syed Shah, MBBS^11*, Hamed Youshanlouei^12*, Stephanie B. Tsai¹³, Mark DeBettencourt^14*, Gauri Shankar^14*, Ahmed Aleem, MD^15*, Nepheli Raptis, MA, BA¹⁶, Bukky Florence Tabiti, MD¹⁷, Peter Doukas, MD^18*, Madelyn Burkhart^19*, Maryam Zia, MD²⁰, Amani Erra^21* and Irum Khan, MD²²

¹University of Illinois at Chicago, Chicago, IL
²University of Illinois At Chicago School of Public Health, Chicago, IL
³UChicago Medicine, Flossmoor, IL
⁴Division of Hematology/Oncology, University of Illinois, Chicago, Chicago, IL
⁵University of Illinois at Chicago, Chicago
⁶Levine Cancer Institute, Atrium Health, Charlotte
⁷Rush University, Chicago
⁸Rush University Medical Center, Chicago, IL
⁹Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
¹⁰University of Chicago Pritzker School of Medicine, Chicago, IL
¹¹University of Chicago, Chicago, IL
¹²Section of Hematology/Oncology, The University of Chicago, Chicago, IL, Chicago
¹³Loyola University Medical Center, Chicago, IL
¹⁴Loyola University Medical Center, Maywood
¹⁵Division of Hematology and Oncology, Loyola University Medical Center, Maywood, IL
¹⁶Loyola University Stritch School of Medicine, Maywood, IL
¹⁷, Northwestern University, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL
¹⁸Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
¹⁹Wake Forest Baptist, Atrium Health, Winston-Salem
²⁰Hematology-Oncology & Cellular Therapy (Division), SSM Health Saint Louis University Hospital, St. Louis, MO
²¹Division of Hematology and Oncology, John H. Stroger Jr. Hospital of Cook County, Chicago, IL
²²Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL

Hervé Dombret, MD, PhD¹, Alexandra Coelho^2*, Laurène Fenwarth, MD, MSc^3*, Jean-Baptiste Micol, MD⁴, Lionel Ades, MD, PhD^5,6, Thomas Cluzeau, MD, PhD⁷, Emmanuel Raffoux, MD^8*, Sylvain Chantepie, MD^9*, Pierre Arnautou, MD^10*, Mathieu Leclerc, MD, PhD^11*, Delphine Lebon, MD^12*, Thorsten Braun, MD, PhD¹³, Ollivier Legrand, MD^14*, Claire Bories, MD^15*, Céline Berthon, MD^16*, Juliette Lambert, MD, PhD^17*, Ahmad Aljijakli, MD^18*, Emilie Lemasle, MD^19*, Pascal Turlure, MD^20*, Benjamin Carpentier, MD^21*, Jamile Frayfer, MD^22*, Stephanie Haiat, MD^23*, Ambroise Marcais, MD, PhD^24*, Isabelle Plantier, MD^25*, Kevin-James Wattebled, MD^26*, Madalina Uzunov, MD^27*, Iona Vaida, MD^28*, Mael Heiblig^29*, Lauris Gastaud, MD^30*, Laure Farnault, MD^31*, Dominique Penther, MD^32*, Nicole Raus, RN^33*, Renaud Buffet, MD^34*, Karine Celli-Lebras, RN^35*, Claude Preudhomme, PharmD, PhD^36*, Nicolas Duployez, PharmD, PhD^37*, Raphael Itzykson³⁸ and Stephane De Botton^39*

¹Department of Clinical Hematology, Saint Louis University Hospital, Université Paris Cité-AP-HP, Paris, France
²ALFA Project Manager, Paris, France
³Hematology Laboratory, CHU Lille, Lille, France
⁴Hematology Department, Gustave Roussy Institute, Villejuif, France
⁵Hématologie clinique, Hôpital Saint-Louis, Paris, France
⁶Department of Hematology, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France
⁷Department for Clinical Hematology, Nice University Hospital, Nice, Provence Alpes Cote d'Azur, France
⁸Hematology Department, Saint Louis Hospital, Paris, France
⁹Basse-Normandie Institute of Hematology, CHU de Caen, Caen, France
¹⁰HIA Percy, Clamart, FRA
¹¹Hematology Department, Henri Mondor University Hospital, AP-HP, Créteil, France
¹²Hematology Department, CHU Amiens, Amiens, France
¹³Clinical Hematology, Avicenne University Hospital, Assistance Publique – Hôpitaux de Paris, Bobigny, France
¹⁴Clinical Hematology and Cellular Therapy Department, Sorbonne University, Saint Antoine Hospital, INSERM UMRs U938, Paris, France
¹⁵Service d'Hématologie, CH de Lens, Lens, FRA
¹⁶Hematology Department, CHRU Lille, Lille, France
¹⁷Clinical Hematology Department, Versailles Hospital, Le Chesnay-Rocquencourt, France
¹⁸CH Argenteuil, Argenteuil, France
¹⁹Hematology Department, Centre Henri Becquerel, Rouen, France
²⁰Service d'Hématologie Clinique, CHU de Limoges, Limoges, France
²¹Saint Vincent de Paul Hospital, Lille, FRA
²²Hospital Saint Faron, Meaux, FRA
²³Centre Hospitalier Sud Francilien, Corbeil-Essonnes, France
²⁴Hopital Necker, Paris, France
²⁵Hopital Victor Provo, Roubaix, France
²⁶CH Dunkerque, Dunkerque, FRA
²⁷Clinical Hematology Department, Pitié-Salpétrière University Hospital, AP-HP, Paris, France
²⁸Centre Hositalier de Pontoise, Pontoise, FRA
²⁹Centre Hospitalier Lyon Sud, Centre Hospitalier Lyon Sud, Service Hématologie, Centre d’Investigation des thérapeutiques en oncologie et hématologie de Lyon (CITHOL), Vourles, Rhône Alpes, France
³⁰Centre Antoine Lacassagne, Nice, France
³¹APHM Hopital La Conception, Marseille, FRA
³²Department of Genetic Oncology, Henri Becquerel Center, CHU Rouen, Rouen, France
³³SFGM-TC coordination, Hôpital Lyon Sud, Lyon, FRA
³⁴ALFA coordination, Hôpital Saint-Louis, Paris, FRA
³⁵ALFA Coordination, Hôpital Saint-Louis, Paris, France
³⁶Laboratory of Hematology-Molecular Biology, CHU Lille, Lille, France
³⁷Laboratory of Hematology-Molecular Biology, Centre Hospitalier Universitaire (CHU) de Lille, Lille, France
³⁸Université de Paris, Unité 944/7212-GenCellDi, INSERM and Centre National de la Recherche Scientifique (CNRS), Paris, France, Paris, France
³⁹Institut Gustave Roussy, Villejuif, France

Pramila Krishnamurthy^1*, Katherine Houghton^2*, Nicola Lorenz^3*, Paula Williams^4*, Lisa Currie^4*, Carlos E. Vigil^5*, Nomthandazo Ziba^2*, Fareedat Bello^2*, Jan Sieluk^5*, Maria Strocchia^5*, Yeran Li^5* and Silke Kapp-Schwoerer^6,7*

¹King’s College Hospital, London, United Kingdom
²RTI Health Solutions, Manchester, United Kingdom
³Bristol Myers Squibb, Munich, Germany
⁴Bristol Myers Squibb, Uxbridge, United Kingdom
⁵Bristol Myers Squibb, Princeton, NJ
⁶Klinikum der Stadt Ludwigshafen, Medizinische Klinik A, Ludwigshafen, Germany
⁷Klinikum der Stadt Ludwigshafen, Zentrum für Haematologische Neoplasien, Ludwigshafen, Germany

Akriti G. Jain, MD¹, Kinaya Smith, MD^2*, Umar Iqbal^3*, Genevieve M Crane, MD, PhD^4*, Ling Zhang, MD⁵, Jay Yang, MD⁶, Ellen K. Ritchie, MD⁷, Alice Mims, MD⁸, Srinivas K Tantravahi, MD⁹, Talha Badar, MD¹⁰, Lindsay A.M. Rein, MD¹¹, Vivian G. Oehler, MD^12*, Jerald P. Radich, MD¹³, B. Douglas Smith, MD¹⁴, Vamsi K. Kota, MD¹⁵, Jorge E. Cortes, MD¹⁵, Anthony M. Hunter, MD¹⁶, Onyee Chan, MD¹⁷, Javier Pinilla-Ibarz, MD, PhD¹⁸, Michael W. Deininger, MD, PhD¹⁹, Sudipto Mukherjee, MD, PhD, MPH¹, Kendra L. Sweet, MD²⁰, Ehab L. Atallah, MD²¹ and Zhuoer Xie, MD, MS²²

¹Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
²Medical College of Wisconsin, Milwaukee, WI
³H. Lee Moffitt Cancer and Research Institute, Tampa
⁴Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland Hts, OH
⁵Department of Pathology and Laboratory Medicine, H. Lee Moffitt Cancer and Research Institute, Tampa, FL
⁶Department of Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, MI
⁷Weill Cornell Medicine and The New York Presbyterian Hospital in New York City, New York, NY
⁸The Ohio State University Comprehensive Cancer Center, Columbus, OH
⁹Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT
¹⁰Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL
¹¹Division of Hematologic Malignancies and Cellular Therapy, Duke Cancer Institute, Durham, NC
¹²Translational Science and Therapeutics, Fred Hutchinson Cancer Center, Seattle, WA
¹³Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Rsch. Ctr., Seattle, WA
¹⁴Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD
¹⁵Georgia Cancer Center, Medical College of Georgia, Augusta University, Augusta, GA
¹⁶Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
¹⁷Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
¹⁸Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
¹⁹Division of Hematology and Hematologic Malignancies, University of Wisconsin Milwaukee, Milwaukee, WI
²⁰Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL
²¹Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
²²Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Massimo Breccia^1*, Alessandra Iurlo, MD, PhD^2*, Fabrizio Pane³, Anna Rita Scortechini, MD^4*, Immacolata Attolico^5*, Marco Santoro^6*, Marco Cerrano, MD^7*, Francesca Lunghi^8*, Alessandro Maggi^9*, Nicola Di Renzo^10*, Valeria Sargentini^11*, Alfonso Piciocchi, MS^11*, Claudia Tringali^12* and Alessandra Malato^13*

¹Sapienza University of Rome, Rome, Italy
²Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
³The University of Naples Federico II, Naples, Italy
⁴Clinica di Ematologia, Azienda Ospedaliera Universitaria delle Marche, Ancona, Italy
⁵Hematology Division, AORN Cardarelli, Naples, Italy
⁶University Hospital Policlinico, Palermo, Italy
⁷Città della Salute e della Scienza, Torino, Italy
⁸San Raffaele Scientific Institute, Milan, Italy
⁹Ospedale Santissima Annunziata, Taranto, Italy
¹⁰Vito Fazzi Hospital, Lecce, Italy
¹¹Fondazione Gimema Onlus, Rome, Italy
¹²Incyte Biosciences Italy S.R.L., Milan, Italy
¹³Hospital Riuniti Villa Sofia Cervello, Palermo, Italy

Wai Yee Jin^1*, Giselle Kidson-Gerber, MBBS, FRACP, FRCPA², Antonia Shand^3*, Antoinette Anazodo^4*, Matthew Greenwood, MBBS, FRACP, FRCPA^5,6, Pietro R. Di Ciaccio, MBBS, FRACP, FRCPA^7,8, Shane Gangatharan, MBBS, FRACP, FRCPA⁹, Ashley Kate McEwan, MBChB, FRACP FRCPA^10*, Kirk Morris, MBBS, FRACP, FRCPA¹¹, Caroline Wilson, MBBS, BS^12*, Rachael Rodgers^13* and Nada Hamad, MBBS, MSc, BSc^14,15,16

¹School of Clinical Medicine, UNSW Medicine & Health, St Vincent's Healthcare Clinical Campus, Faculty of Medicine and Health, The University of New South Wales, Sydney, NSW, Australia
²Department of Haematology, Prince of Wales Hospital, Sydney, Randwick, NSW, Australia
³Department of Maternal and Fetal Medicine, Royal Hospital for Women, Randwick, NSW, Australia
⁴Nelune Comprehensive Cancer Centre, Prince of Wales Hospital, Randwick, New South Wales, Australia, Randwick, AUS
⁵Royal North Shore Hospital, Sydney, NSW, Australia
⁶University of Sydney, Sydney, Australia
⁷Department of Haematology, The Canberra Hospital, Canberra, Australia
⁸School of Medicine and Psychology, Australian National University, Canberra, Canberra, Australia
⁹Department of Haematology, Fiona Stanley Hospital, Murdoch, Australia
¹⁰Department of Haematology, Liverpool Hospital, Liverpool, Australia
¹¹Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia
¹²Department of Haematology/Obstetric Medicine, Mater Hospital Brisbane, South Brisbane, Australia
¹³Department of Reproductive Medicine, Royal Hospital for Women, Sydney, NSW, Australia
¹⁴Haematology Department, The Kinghorn Cancer Centre, St Vincent's Hospital, Darlinghurst, NSW, Australia
¹⁵School of Clinical Medicine, Faculty of Medicine and Health, The University of New South Wales, Sydney, NSW, Australia
¹⁶School of Medicine, University of Notre Dame, Sydney, Australia

Cynthia Eleanya, MD^1*, Stacey Doran, MD^1*, Amy Chai, RN^2*, Rebecca Schwartz, RN^3*, Jessica Andrade, LCSW-C^4*, Dimana Dimitrova, MD^2*, Jennifer Hendricks, LCSW-C^4*, Mustafa A. Hyder, MD², Rechache Kamil, MD^1*, Ruby Sabina, FNP-BC^2*, Jennifer Sponaugle, PA-C^2*, Christopher G. Kanakry, MD² and Jennifer A. Kanakry, MD^2*

¹Center for Immuno-Oncology/National Cancer Institute, National Institutes of Health, Bethesda, MD
²Center for Immuno-Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD
³Office of the Clinical Director/National Cancer Institute, National Institutes of Health, Bethesda, MD
⁴Social Work Department/Clinical Center, National Institutes of Health, Bethesda, MD

Luke Fletcher¹, Nicole Niehoff, PhD, MPH^2*, Sneha Sura^1*, Tom Liu, MS^2*, Karen Todoroff^1*, William Zhang, MSc^2* and Ira Zackon, MD¹

¹Ontada, Boston, MA
²GSK plc, Collegeville, PA

Aniket Vijay Rao, MD^1*, Aditya Sanjeevi, MD, MBBS², Daniel Idoate Jose Domench^3*, Samikchhya Keshary Bhandari^4* and Purva Shah, MBBS^2*

¹Rochester General Hospital, Rochester
²Department of Internal Medicine, Rochester General Hospital, Rochester, NY
³Rochester General Hospital, Rochester, NY
⁴Tribhuvan University teaching hospital, Kathmandu, Nepal

Tracelyn Freeman, PharmD, BCOP^1*, Alma Habib, MD², Ying Huang, MS, MA³, Pooja Kumar, PharmD, BCOP^1*, Allyson Waller, PharmD, BCOP^1*, Megan Fleming, PharmD, BCOP^1*, Kelsey McMillan, MS^4*, Natalia Hartzler, PharmD, BCOP^1*, Gregory K Behbehani, MD, PhD⁵, James S. Blachly, MD⁵, Bradley Wayne Blaser, MD, PhD⁵, Uma Borate, MD⁵, Ann-Kathrin Eisfeld, MD⁵, Nicole R. Grieselhuber, MD, PhD⁵, Karilyn T. Larkin, MD⁵, Shinae Lee, PharmD^1*, Meixiao Long, MD, PhD⁵, Alice Mims, MD⁵, Andrew Srisuwananukorn, MD⁶, Kieran D Sahasrabudhe, MD⁷ and Kristin L Koenig, MD⁵

¹Department of Pharmacy, The James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus, OH
²Division of Hematology, The Ohio State University, Columbus, OH
³Division of Hematology, Department of Statistics, The Ohio State University Wexner Medical Center, Columbus, OH
⁴The Ohio State University College of Pharmacy, Columbus, OH
⁵Division of Hematology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH
⁶The Ohio State University, Columbus, OH
⁷The University of Wisconsin Carbone Cancer Center, Madison, WI

Fayaz Khan^1*, Kenan Rahima, MD^1*, Brian Patrick Singeltary, DO^1*, Taraneh Zamani^1*, Madelyn Mirande^1* and Thulasee Jose, MD²

¹TriHealth Good Samaritan Hospital, Cincinnati, OH
²Stanford University, California

Elias Jabbour, MD¹, David Wei, PhD^2*, Hongbo Yang, PhD^3*, Kejal Jadhav, B.Pharm, MS^2*, Wei Song, PhD^4*, Yajin Zhao, MS^5*, Anran Shao, MPH^5*, Samantha Tomicki, MPH^5*, Daisy Yang, Pharm.D., BCOP^2*, Andrea Damon, PhD^2*, Islam Sadek, MD^2* and Vamsi K. Kota, MD⁶

¹The University of Texas MD Anderson Cancer Center, Houston, TX
²Novartis Pharmaceuticals Corporation, East Hanover, NJ
³Analysis Group, Inc., Boston, MA
⁴Analysis Group Inc., Boston, MA
⁵Genesis Research Group, Hoboken, NJ
⁶Georgia Cancer Center, Medical College of Georgia, Augusta University, Augusta, GA

Elisabetta Abruzzese, MD¹, Ekaterina Chelysheva, MD, PhD^2*, Mouna Bardey-Kanaan^3*, Romuald Soichez^3*, Nhan Thanh Nguyen^3*, Deborah Kelly^3*, Federica Rizzo^3*, Petros Patos^3* and Jane Apperley, FRCP, FRCPath, MB ⁴

¹S. Eugenio Hospital, Tor Vergata University, ASL Roma 2, Rome, Italy
²National Medical Research Center for Hematology, Moscow, Russian Federation
³Incyte Biosciences International Sàrl, Morges, Switzerland
⁴Centre for Haematology, Department of Immunology and Inflammation, Hammersmith Hospital, London, United Kingdom

Alexander J. Ambinder, MD, MPH¹, Mark J. Levis², Xin Wang, MD³, Keith W. Pratz, MD⁴ and Andrew H Matthews, MD^3*

¹Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD
²Johns Hopkins University, Baltimore, MD
³Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA
⁴University of Pennsylvania, Philadelphia, PA

Erica E Fortune, PhD^1*, Sabrina Pink, PhD^1*, Kara Doughtie, MA^1*, Claire Saxton, MBA^1*, Thomas W. LeBlanc, MD, MA, MS², Joanne Buzaglo, PhD^3*, Aude Roborel de Climens, PhD^3*, France Ginchereau Sowell, PhD^3*, Anubha Shukla, MA^4* and Melissa F Miller, PhD, MPH^1,5*

¹Cancer Support Community, Research & Training Institute, Washington, DC
²Duke Cancer Institute, Duke University School of Medicine, Durham, NC
³Patient Centered Solutions, IQVIA, Durham, NC
⁴PCS, Bangalore, India
⁵Life with Cancer, Inova Schar Cancer Institute, Fairfax, VA

Mahesh Swaminathan, MD^1*, Daniel Aaron Fox, MD^2*, Kelly S. Chien, MD³, Guillermo Montalban-Bravo, MD¹, Danielle Hammond, MD¹, Alexandre Bazinet, MD^1*, Sherry Pierce, BSN, BA^1*, Hyunsoo Hwang, MS^4*, Xuelin Huang, PhD^4*, Koji Sasaki, MD¹, Tapan M. Kadia, MD¹, Koichi Takahashi, MD, PhD⁵, Courtney D. DiNardo, MD, MSc¹, Elias Jabbour, MD⁶, Naval Daver, MD¹, Hagop M. Kantarjian, MD¹ and Guillermo Garcia-Manero, MD⁷

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Baylor College of Medicine, Houston, TX
³Department of Leukemia, MD Anderson, Houston, TX
⁴Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX